Selected research
Industry Research
Adeno Associated Virus Production Industry Research Report 2026
Market perspective
The global Adeno Associated Virus Production market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Adeno Associated Virus Production market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Adeno Associated Virus Production market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Adeno Associated Virus Production market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Adeno Associated Virus Production include Biovian, Charles River, Lonza, Merck Group, OriGene, Sigma-Aldrich, SIRION Biotech, Thermo Fisher Scientific and Vigene Biosciences and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Adeno Associated Virus Production market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Adeno Associated Virus Production.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Adeno Associated Virus Production Market by Company
Biovian
Charles River
Lonza
Merck Group
OriGene
Sigma-Aldrich
SIRION Biotech
Thermo Fisher Scientific
Vigene Biosciences
Yeasen Aav
Adeno Associated Virus Production Segment by Type
Large-Scale Production
Customized Production
Adeno Associated Virus Production Segment by Application
Vaccine Production
Gene Therapy
Others
Adeno Associated Virus Production Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adeno Associated Virus Production market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adeno Associated Virus Production and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adeno Associated Virus Production.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Adeno Associated Virus Production companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Large-Scale Production
- Customized Production
Applications
- Vaccine Production
- Gene Therapy
- Others
Companies covered
- Biovian
- Charles River
- Lonza
- Merck Group
- OriGene
- Sigma-Aldrich
- SIRION Biotech
- Thermo Fisher Scientific
- Vigene Biosciences
- Yeasen Aav
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Adeno Associated Virus Production by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Large-Scale Production
- 2.2.3 Customized Production
- 2.3 Adeno Associated Virus Production by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Vaccine Production
- 2.3.3 Gene Therapy
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Adeno Associated Virus Production Breakdown Data by Type
- 3.1 Global Adeno Associated Virus Production Historic Market Size by Type (2021-2026)
- 3.2 Global Adeno Associated Virus Production Forecasted Market Size by Type (2027-2032)
4 Adeno Associated Virus Production Breakdown Data by Application
- 4.1 Global Adeno Associated Virus Production Historic Market Size by Application (2021-2026)
- 4.2 Global Adeno Associated Virus Production Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Adeno Associated Virus Production Market Perspective (2021-2032)
- 5.2 Global Adeno Associated Virus Production Growth Trends by Region
- 5.2.1 Global Adeno Associated Virus Production Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Adeno Associated Virus Production Historic Market Size by Region (2021-2026)
- 5.2.3 Adeno Associated Virus Production Forecasted Market Size by Region (2027-2032)
- 5.3 Adeno Associated Virus Production Market Dynamics
- 5.3.1 Adeno Associated Virus Production Industry Trends
- 5.3.2 Adeno Associated Virus Production Market Drivers
- 5.3.3 Adeno Associated Virus Production Market Challenges
- 5.3.4 Adeno Associated Virus Production Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Adeno Associated Virus Production Players by Revenue
- 6.1.1 Global Top Adeno Associated Virus Production Players by Revenue (2021-2026)
- 6.1.2 Global Adeno Associated Virus Production Revenue Market Share by Players (2021-2026)
- 6.2 Global Adeno Associated Virus Production Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Adeno Associated Virus Production Head Office and Area Served
- 6.4 Global Adeno Associated Virus Production Players, Product Type & Application
- 6.5 Global Adeno Associated Virus Production Manufacturers Established Date
- 6.6 Global Adeno Associated Virus Production Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Adeno Associated Virus Production Market Size (2021-2032)
- 7.2 North America Adeno Associated Virus Production Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Adeno Associated Virus Production Market Size by Country (2021-2026)
- 7.4 North America Adeno Associated Virus Production Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Adeno Associated Virus Production Market Size (2021-2032)
- 8.2 Europe Adeno Associated Virus Production Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Adeno Associated Virus Production Market Size by Country (2021-2026)
- 8.4 Europe Adeno Associated Virus Production Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Adeno Associated Virus Production Market Size (2021-2032)
- 9.2 Asia-Pacific Adeno Associated Virus Production Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Adeno Associated Virus Production Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Adeno Associated Virus Production Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Adeno Associated Virus Production Market Size (2021-2032)
- 10.2 South America Adeno Associated Virus Production Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Adeno Associated Virus Production Market Size by Country (2021-2026)
- 10.4 South America Adeno Associated Virus Production Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Adeno Associated Virus Production Market Size (2021-2032)
- 11.2 Middle East & Africa Adeno Associated Virus Production Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Adeno Associated Virus Production Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Adeno Associated Virus Production Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Biovian
- 12.1.1 Biovian Company Information
- 12.1.2 Biovian Business Overview
- 12.1.3 Biovian Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.1.4 Biovian Adeno Associated Virus Production Product Portfolio
- 12.1.5 Biovian Recent Developments
- 12.2 Charles River
- 12.2.1 Charles River Company Information
- 12.2.2 Charles River Business Overview
- 12.2.3 Charles River Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.2.4 Charles River Adeno Associated Virus Production Product Portfolio
- 12.2.5 Charles River Recent Developments
- 12.3 Lonza
- 12.3.1 Lonza Company Information
- 12.3.2 Lonza Business Overview
- 12.3.3 Lonza Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.3.4 Lonza Adeno Associated Virus Production Product Portfolio
- 12.3.5 Lonza Recent Developments
- 12.4 Merck Group
- 12.4.1 Merck Group Company Information
- 12.4.2 Merck Group Business Overview
- 12.4.3 Merck Group Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.4.4 Merck Group Adeno Associated Virus Production Product Portfolio
- 12.4.5 Merck Group Recent Developments
- 12.5 OriGene
- 12.5.1 OriGene Company Information
- 12.5.2 OriGene Business Overview
- 12.5.3 OriGene Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.5.4 OriGene Adeno Associated Virus Production Product Portfolio
- 12.5.5 OriGene Recent Developments
- 12.6 Sigma-Aldrich
- 12.6.1 Sigma-Aldrich Company Information
- 12.6.2 Sigma-Aldrich Business Overview
- 12.6.3 Sigma-Aldrich Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.6.4 Sigma-Aldrich Adeno Associated Virus Production Product Portfolio
- 12.6.5 Sigma-Aldrich Recent Developments
- 12.7 SIRION Biotech
- 12.7.1 SIRION Biotech Company Information
- 12.7.2 SIRION Biotech Business Overview
- 12.7.3 SIRION Biotech Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.7.4 SIRION Biotech Adeno Associated Virus Production Product Portfolio
- 12.7.5 SIRION Biotech Recent Developments
- 12.8 Thermo Fisher Scientific
- 12.8.1 Thermo Fisher Scientific Company Information
- 12.8.2 Thermo Fisher Scientific Business Overview
- 12.8.3 Thermo Fisher Scientific Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.8.4 Thermo Fisher Scientific Adeno Associated Virus Production Product Portfolio
- 12.8.5 Thermo Fisher Scientific Recent Developments
- 12.9 Vigene Biosciences
- 12.9.1 Vigene Biosciences Company Information
- 12.9.2 Vigene Biosciences Business Overview
- 12.9.3 Vigene Biosciences Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.9.4 Vigene Biosciences Adeno Associated Virus Production Product Portfolio
- 12.9.5 Vigene Biosciences Recent Developments
- 12.10 Yeasen Aav
- 12.10.1 Yeasen Aav Company Information
- 12.10.2 Yeasen Aav Business Overview
- 12.10.3 Yeasen Aav Revenue in Adeno Associated Virus Production Business (2021-2026)
- 12.10.4 Yeasen Aav Adeno Associated Virus Production Product Portfolio
- 12.10.5 Yeasen Aav Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst